drugset / Trial / NCT00085761

Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy

NCT00085761

Phase 3 Terminated NeurogesX
RandomizedDouble-blindTreatment

Summary

The purpose of the study is to determine if an investigational drug, NGX-4010 (high-concentration capsaicin patch), is safe, tolerable and effective in treating painful HIV-associated neuropathy.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Capsaicin Small molecule Topical